Covered recipient · General Payments record
TODD R SHEPLER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$3,995.87
- Reported across 115 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $452.45 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $229.53 | 8 |
| Bausch & Lomb Americas Inc. | $66.46 | 3 |
| Tarsus Pharmaceuticals, Inc. | $51.43 | 2 |
| BIOTISSUE HOLDINGS INC. | $48.41 | 1 |
| Astellas Pharma US Inc | $23.56 | 1 |
| Harrow Eye, LLC | $18.94 | 1 |
| Alcon Laboratories Inc | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.04 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106082859 | CMS |
| ABBVIE INC. | $25.76 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106082861 | CMS |
| ABBVIE INC. | $30.04 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106082863 | CMS |
| ABBVIE INC. | $30.08 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106082865 | CMS |
| ABBVIE INC. | $31.20 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106082867 | CMS |
| ABBVIE INC. | $27.80 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106082869 | CMS |
| ABBVIE INC. | $32.17 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106082871 | CMS |
| ABBVIE INC. | $22.44 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106082873 | CMS |
| Alcon Vision LLC | $14.12 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110631242 | CMS |
| Astellas Pharma US Inc | $23.56 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139425023 | CMS |
| Bausch & Lomb Americas Inc. | $19.60 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140461180 | CMS |
| Bausch & Lomb Americas Inc. | $23.28 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140461182 | CMS |
| Bausch & Lomb Americas Inc. | $23.58 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140461184 | CMS |
| BIOTISSUE HOLDINGS INC. | $48.41 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148775185 | CMS |
| Harrow Eye, LLC | $18.94 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145615593 | CMS |
| Tarsus Pharmaceuticals, Inc. | $23.45 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139131902 | CMS |
| Tarsus Pharmaceuticals, Inc. | $27.98 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139131904 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.